Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Nakanishi ( (JP:7716) ).
Nakanishi Inc. reported that, despite board authorization in February 2026 to repurchase up to 1.5 million common shares for a maximum of JPY 2.5 billion by year-end, it did not buy back any shares during the March 1–31, 2026 period. The lack of repurchase activity, with total shares and costs at zero as of March 31, suggests the company is preserving capital or waiting for more favorable market conditions before executing its buyback program, leaving current share liquidity and ownership structure unchanged for now.
The most recent analyst rating on (JP:7716) stock is a Buy with a Yen3123.00 price target. To see the full list of analyst forecasts on Nakanishi stock, see the JP:7716 Stock Forecast page.
More about Nakanishi
Nakanishi Inc., listed on the Tokyo Stock Exchange, specializes in innovative grinding technology applied across dental, surgical, and industrial fields. The company offers a differentiated product lineup under world-class brands, supplying medical and industrial equipment to 145 countries as part of its mission to advance healthcare and improve quality of life globally.
Average Trading Volume: 250,836
Technical Sentiment Signal: Buy
Current Market Cap: Yen227.8B
For an in-depth examination of 7716 stock, go to TipRanks’ Overview page.